Many ECM remodeling enzymes including MMPs and LOX family oxidases are expressed during malignant transformation, progression, and metastasis of CRC [116]; increased MMPs and LOX expression in CRC correlate with advanced disease progression and a poor prognosis [40,93,94,97,98,99,104]. The gene discussed is LOX; the disease is colorectal carcinoma.